ArticleCell reports. Medicine2023

High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma.

Nadia Arang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.